Related Experiment Video
Updated: May 4, 2026

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
Published on: April 29, 2022
PHLPP1 regulates contact inhibition by dephosphorylating Mst1 at the inhibitory site
Sujin Jung1, Jeong Gu Kang1, Ju Hee Lee2
1Targeted Gene Regulation Research Center, KRIBB, 125 Gwahak-ro, Yuseong-gu, Deajeon, South Korea.
Abstract:
Contact inhibition has been largely elusive despite that a loss of contact inhibition is a critical event for cancer development and progression. Here, we report that PHLPP1 is a binding protein for Mst1 and it modulates the Hippo pathway by dephosphorylating Mst1 at the inhibitory Thr(387) of Mst1. Yap1 was localized predominantly in the nucleus but marginally in the cytoplasm in HeLa cells under sparse conditions, whereas the functional protein was more directed to sequestration in the cytoplasm under dense environments. Furthermore, loss of PHLPP1 resulted in a failure of the apoptotic control. It is interesting that down-regulated expression of PHLPP1 appears to mimic the loss of contact inhibition, a hallmark of cancer.
Insights
Researchers found that PHLPP1 protein regulates the Hippo pathway by interacting with Mst1, impacting cell growth control. Loss of PHLPP1 mimics cancer
Area of Science:
- Cell biology
- Cancer research
- Molecular biology
Background:
- Loss of contact inhibition is crucial for cancer progression.
- The Hippo pathway regulates cell proliferation and apoptosis.
- PHLPP1's role in contact inhibition and cancer is largely unknown.
Purpose of the Study:
- To investigate the role of PHLPP1 in regulating the Hippo pathway.
- To determine how PHLPP1 influences contact inhibition and cancer development.
Main Methods:
- Co-immunoprecipitation to identify binding partners.
- Western blotting to assess protein phosphorylation.
- Immunofluorescence to determine protein localization.
- Cell culture under sparse and dense conditions.
Main Results:
- PHLPP1 binds to Mst1 and dephosphorylates it at Thr(387), modulating Hippo pathway activity.
- Yap1 localization shifts from nucleus to cytoplasm under dense conditions, indicating regulation by PHLPP1.
- Loss of PHLPP1 impairs apoptotic control and mimics the loss of contact inhibition.
Conclusions:
- PHLPP1 is a key regulator of the Hippo pathway and contact inhibition.
- Down-regulation of PHLPP1 contributes to cancer development by disrupting normal cell growth control.
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
IP3/DAG Signaling Pathway

